Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors

Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings

(2010) Gill Spurlock et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array

(2009) Kiran K. Mantripragada et al.   GENES CHROMOSOMES & CANCER

TP53Mutation Analysis of Malignant Peripheral Nerve Sheath Tumors

(2009) Robert M. Verdijk et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1

(2009) Hilde Brems et al.   LANCET ONCOLOGY

The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers

(2009) S. Veeriah et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization

(2008) K. K. Mantripragada et al.   CLINICAL CANCER RESEARCH

Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data

(2008) Christiaan Klijn et al.   NUCLEIC ACIDS RESEARCH

[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study

(2007) R. E. Ferner et al.   ANNALS OF ONCOLOGY